dypracet 20/500 milligram tablets
auden mckenzie (pharma division) ltd - paracetamol, dihydrocodeine bitartrate - tablets - 20/500 milligram - dihydrocodeine and paracetamol
dypracet 30/500 milligram tablets
auden mckenzie (pharma division) ltd - paracetamol, dihydrocodeine bitartrate - tablets - 30/500 milligram - dihydrocodeine and paracetamol
paramol 10/500 milligram tablets
galen limited - paracetamol dihydrocodeine bitartrate - tablets - 10/500 milligram
dihydrocodeine bitartrate, acetaminophen and caffeine tablet
physicians total care, inc. - dihydrocodeine bitartrate (unii: 8lxs95bsa9) (dihydrocodeine - unii:n9i9hdb855), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - dihydrocodeine bitartrate 32 mg - acetaminophen, caffeine, and dihydrocodeine bitartrate tablets are indicated for the relief of moderate to moderately severe pain. this combination product is contraindicated in persons with hypersensitivity to dihydrocodeine, codeine, acetaminophen, caffeine, or any of the inactive components listed above, or any situation where opioids are contraindicated including significant respiratory depression (in unmonitored settings or in the absence of resuscitative equipment), acute or severe bronchial asthma or hypercapnia, and paralytic ileus. this combination product is subject to the provisions of the controlled substance act, and has been placed in schedule iii. dihydrocodeine can produce drug dependence of the codeine type and therefore has the potential of being abused. like other opioid analgesics, dihydrocodeine may produce subjective effects other than analgesia (e.g., euphoria, relaxation), which may contribute to abuse by some patients. psychological dependence, physical dependence, and tolerance may d
dihydrocodeine tablets
wockhardt uk limited - dihydrocodeine tartrate - tablet - dihydrocodeine tartrate 30 mg - analgesics
dihydrocodeine 30mg tablets
pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - dihydrocodeine tartrate - tablet - dihydrocodeine tartrate 30 mg - analgesics
dihydrocodeine controlled release actavis
teva pharma (new zealand) limited - dihydrocodeine hydrogen tartrate 60mg - modified release tablet - 60 mg - active: dihydrocodeine hydrogen tartrate 60mg excipient: calcium sulfate dihydrate copovidone glyceryl behenate sodium stearyl fumarate - dihydrocodeine controlled release actavis tablets are recommended for use in the treatment of post-operative pain, and pain associated with cancer.
dihydrocodeine 30mg tablets
teva uk ltd - dihydrocodeine tartrate - oral tablet - 30mg
dihydrocodeine 30mg tablets
a a h pharmaceuticals ltd - dihydrocodeine tartrate - oral tablet - 30mg
dihydrocodeine 30mg tablets
actavis uk ltd - dihydrocodeine tartrate - oral tablet - 30mg